MAPT and Alzheimer disease: Further studies are needed to clarify the relationship between cognitive improvement and the levels of Aβ and phospho-tau in taurine-treated wild type, SAPM8, and other AD models, such as 5XFAD, 3xTg, and APP/PS1 mice.